SCHEMBL4480585

SCHEMBL4480585

Cc1cc(C)c2c(C#N)c(C=CC(=O)N3CCOCC3)n(Cc3ccccc3)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HTT P42858 3/20 0.43
HIF1A Q16665 1/20 0.43
KMT2A Q03164 6/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 5/20 0.43
MEN1 O00255 4/20 0.43
TSHR P16473 2/20 0.43
PSMD14 O00487 1/20 0.43
RAB9A P51151 4/20 0.41
POLB P06746 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
APP P05067 1/20 0.40
MAPT P10636 1/20 0.38
NPC1 O15118 3/20 0.38
KHK P50053 1/20 0.37
MAPK1 P28482 1/20 0.37
BRD4 O60885 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4480577 1.00 ALDH1A1 (0.43) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4491963 0.88 RAB9A (0.40) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4491967 0.88 RAB9A (0.40) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4475496 0.88 ALDH1A1 (0.44) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4475482 0.88 ALDH1A1 (0.44) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4488423 0.86 RAB9A (0.42) ALDH1A1HTTKMT2AKDM4EHPGD
SCHEMBL4488431 0.86 RAB9A (0.42) ALDH1A1HTTKMT2AKDM4EHPGD
SCHEMBL4481881 0.86 KMT2A (0.50) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4481877 0.86 KMT2A (0.50) ALDH1A1HTTHIF1AKMT2AKDM4E
SCHEMBL4481338 0.82 ALDH1A1 (0.38) ALDH1A1HTTKMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582651-B2 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-01 US disclosed
US-20060167038-A1 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167038-A1 Pyrrolopyridine derivative and use thereof OPRD1, TRPV1, OPRM1 ALDH1A1 1363/4885HTT 2457/4885HIF1A 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.